Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy

Blood Purification

Volumn 33, Issue 1-3, 2012, Pages 80-87

  Balik, Martin ^a   Zakharchenko, Mykhaylo ^a   Otahal, Michal ^a   Hruby, Jan ^a   Polak, Ferdinand ^a   Rusinova, Katerina ^a   Stach, Zdenek ^a   Vavrova, Jaroslava ^b   Jabor, Antonin ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Acute renal failure; Anticoagulation; Citrate; Hemodiafiltration; Hemofiltration; Renal replacement therapy

Indexed keywords

ACID CITRATE DEXTROSE; GLUCOSE; HEPARIN; LACTIC ACID; POLYSULFONE;

ANTICOAGULANT THERAPY; ARTICLE; CALORIE; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; PRIORITY JOURNAL;

ACUTE KIDNEY INJURY; ANTICOAGULANTS; CITRIC ACID; EQUIPMENT DESIGN; GLUCOSE; HEPARIN; HUMANS; LACTIC ACID; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY;

EID: 84855161269     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000334641     Document Type: Article

References (26)

1. Uchino S, Bellomo R, Morimatsu H, Mor-gera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA: Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (BEST kidney) investigators. Intensive Care Med 2007; 33:1563-1570.
2. Kleger GR, Fässler E: Can circuit lifetime be a quality indicator in continuous renal replacement therapy in the critically ill? Int J Artif Organs 2010; 33: 139-146.
3. Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR: Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 2006; 32: 188-202.
4. Monchi M, Berghmans D, Ledoux D, Caniv-et JL, Dubois B, Damas P: Citrate vs. heparin for anticoagulation in continuous venove-nous hemofiltration: a prospective randomized study. Intensive Care Med 2005; 30: 260-265.
5. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF: Citrate anticoagulation for continuous veno-venous hemofiltration. Crit Care Med 2009; 37: 545-552.
6. Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC: Regional citrate versus systemic heparin for antico-agulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transpla nt 2011; 26: 232-239.
7. Balik M, Waldauf P, Plasil P, Pachl J: Prosta-cyclin versus citrate in continuous haemo-diafiltration: an observational study in patients with high risk of bleeding. Blood Pu-rif 2005; 23: 325-329.
8. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A: Citrate pharma-cokinetics and metabolism in cirrhotic and non-cirrhotic critically ill patients. Crit Care Med 2003; 31:2450-2455.
9. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T: Increased total to ionised calcium ratio during continuous venovenous hemo-dialysis with regional citrate anticoagula-tion. Crit Care Med 2001; 29:748-752.
10. Oudemans-van Straaten HM: Citrate anti-coagulation for continuous renal replacement therapy in the critically ill. Blood Purif 2010; 29: 191-196.
11. Bollmann MD, Revelly JP, Tappy L, Berger MM, Schaller MD, Cayeux MC, Martinez A, Chiolero RL: Effect of bicarbonate and lac-tate buffer on glucose and lactate metabolism during haemodiafiltration in patients with multiple organ failure. Intensive Care Med 2004; 30:1103-1110.
12. Morgera S, Schneider M; Slowinski T, Var-gas-Hein O, Zuckermann-Becker H, Peters H, Kindgen-Milles D, Neumayer HH: A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 2009; 37: 2018-2024.
13. Whitfield LR, Levy G: Permeability of human and rat red blood cell to citrate. Thromb Res 1981; 21:681-684.
14. Oudemans van Straaten HM, Bellomo R, Kellum JA: Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? Crit Care 2011; 15:202.
15. Marino PL, Sutin KM: Hemodynamic monitoring; in Marino PL, Sutin KM (eds): The ICU Book. Philadelphia, Lippincott, Williams & Wilkins, 2007, ed 3, pp 194-208.
16. Fencl V, Jabor A, Kazda A, Figge J: Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med 2000; 162: 2246-2251.
17. Ali Y, Abouelnaga S, Khalaf H, Kamel Y: Physical chemical approach versus traditional technique in analyzing blood gases and electrolytes during liver transplant surgery. Transplant Proc 2010; 42:861-864.
18. Swartz R, Pasko D, O'Toole J, Starmann B: Improving the delivery of continuous renal replacement therapy using regional citrate anticoag ulation. Clin Nephrol 2004; 61: 134-143.
19. Chadha V, Garg U, Warady BA, Alon US: Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 2002; 17: 819-82 4.
20. Mariano F, Tedeschi L, Morselli M, Stella M, Triolo G: Normal citratemia and metabolic tolerance of citrate anticoagulation for he-modiafiltration in severe septic shock burn patients. Intensive Care Med 2010; 36:1735-1743.
21. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warmock DG: Simplified citrate antico-agulation for continuous renal replacement therapy. Kidney Int 2001; 60:370-374.
22. Levy B, Mansart A, Montemont C, Gibot S, Mallie JP, Regnault V, Lecompte T, Lacolley P: Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock. Intensive Care Med 2007; 33: 495-502.
23. Leverve X, Mustafa I, Novak I, Krouzecky A, Rokyta R, Matejovic M, Ichai C: Lactate metabolism in acute uremia. J Ren Nutr 2005; 15: 58-62.
24. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Continuous is not continuous: the incidence and impact of circuit 'downtime' on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003; 29:575-578.
25. Hetzel GR, Taskaya G, Sucker C, Henners-dorf M, Grabensee B, Schmitz M: Citrate plasma levels in patients under regional an-ticoagulation in continuous venovenous he-mofiltration. Am J Kidney Dis 2006; 48:806-811.
26. Kozik-Jaromin J, Nier V, Heemann U, Krey-mann B, Bohler J: Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant 2009; 24:2244-2251.